Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis
NCT01178372Phase 4Unknown
- Sponsor
- Govind Ballabh Pant Hospital
- Start
- Sep 2008
- Modality
- Multi-strain Products
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of VSL#3 in hepatic encephalopathy (HE) (3 arms), sponsored by Govind Ballabh Pant Hospital. Primary endpoint: Episode of Overt Hepatic Encephalopathy at 6 months. Status: unknown.
02
Drugs
VSL#3
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT01178372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01178372.